- Cilostazol for Secondary Prevention of Stroke: Should the Guidelines Perhaps Be Extended?
-
Galyfos G, Sianou A
- KMID: 2396187
- Vasc Spec Int.
- 2017 Sep;33(3):89-92.
- doi: 10.5758/vsi.2017.33.3.89
Cilostazol belongs to the new generation antiplatelet agents that have been introduced and studied regarding a potential role in cardiovascular disease prevention or treatment. Although data on peripheral artery disease... -
- CITED
-
- Close
- SHARE
-
- Close
- Traumatic Carotid Artery Dissection: A Different Entity without Specific Guidelines
-
Galyfos G, Filis K, Sigala F, Sianou A
- KMID: 2162123
- Vasc Spec Int.
- 2016 Mar;32(1):1-5.
- doi: 10.5758/vsi.2016.32.1.1
According to literature data, there are no distinct guidelines regarding the proper diagnostic and therapeutic management of traumatic carotid artery dissection (TCAD). Although most of cases evaluated in research studies... -
- CITED
-
- Close
- SHARE
-
- Close
- Autologous Platelet-Rich Plasma for Nonhealing Ulcers: A Comparative Study
-
Tsachiridi M, Galyfos G, Andreou A, Sianou A, Sigala F, Zografos G, Filis K
- KMID: 2448811
- Vasc Spec Int.
- 2019 Mar;35(1):22-27.
- doi: 10.5758/vsi.2019.35.1.22
PURPOSE: The use of platelet-rich plasma (PRP) for the treatment of nonhealing ulcers is a relatively new technique. Although it seems to result in a satisfying level of healing and... -
- CITED
-
- Close
- SHARE
-
- Close
